StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.95−0.09 (-4.41%)

Close on Nov 18, 2026Market cap $7.90MP/E 0.0Yield –

Kyntra Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Kyntra Bio's revenue for the twelve months ending Jun 30, 2026 was $4.62M, down 37.1% year over year. For fiscal 2025 it was $6.44M, down 78.3% from the year before. Over ten years it grew -28.4% a year on average. The highest annual figure on record is $256.58M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.44M-78.3%
FY2024Dec 31, 2024$29.62M-36.7%
FY2023Dec 31, 2023$46.80M-66.7%
FY2022Dec 31, 2022$140.73M-40.2%
FY2021Dec 31, 2021$235.31M+33.5%
FY2020Dec 31, 2020$176.32M-31.3%
FY2019Dec 31, 2019$256.58M+20.5%
FY2018Dec 31, 2018$212.96M+62.6%
FY2017Dec 31, 2017$131.00M-28.5%
FY2016Dec 31, 2016$183.19M+1.3%
FY2015Dec 31, 2015$180.83M+31.4%
FY2014Dec 31, 2014$137.60M+34.7%
FY2013Dec 31, 2013$102.17M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.47M-209.3%
Q1 FY2026Mar 31, 2026$3.74M+36.5%
Q4 FY2025Dec 31, 2025$1.28M-59.3%
Q3 FY2025Sep 30, 2025$1.08M+774.8%
Q2 FY2025Jun 30, 2025$1.35M+35.1%
Q1 FY2025Mar 31, 2025$2.74M-89.2%
Q4 FY2024Dec 31, 2024$3.14M-88.4%
Q3 FY2024Sep 30, 2024$123.00K-99.7%
Q2 FY2024Jun 30, 2024$998.00K-97.7%
Q1 FY2024Mar 31, 2024$25.36M-29.9%
Q4 FY2023Dec 31, 2023$27.14M-21.0%
Q3 FY2023Sep 30, 2023$40.13M+155.1%
Q2 FY2023Jun 30, 2023$44.32M+48.7%
Q1 FY2023Mar 31, 2023$36.16M-40.6%
Q4 FY2022Dec 31, 2022$34.37M+107.7%
Q3 FY2022Sep 30, 2022$15.74M-89.9%
Q2 FY2022Jun 30, 2022$29.81M+22.3%
Q1 FY2022Mar 31, 2022$60.83M+58.3%
Q4 FY2021Dec 31, 2021$16.54M-74.5%
Q3 FY2021Sep 30, 2021$155.97M+254.2%
Q2 FY2021Jun 30, 2021$24.36M-43.2%
Q1 FY2021Mar 31, 2021$38.43M+57.5%
Q4 FY2020Dec 31, 2020$65.00M+715.1%
Q3 FY2020Sep 30, 2020$44.03M+32.7%
Q2 FY2020Jun 30, 2020$42.89M-77.6%
Q1 FY2020Mar 31, 2020$24.40M+2.3%
Q4 FY2019Dec 31, 2019$7.97M-92.6%
Q3 FY2019Sep 30, 2019$33.17M+14.3%
Q2 FY2019Jun 30, 2019$191.57M+335.9%
Q1 FY2019Mar 31, 2019$23.86M-25.3%
Q4 FY2018Dec 31, 2018$108.06M+251.6%
Q3 FY2018Sep 30, 2018$29.03M-28.4%
Q2 FY2018Jun 30, 2018$43.95M+45.2%
Q1 FY2018Mar 31, 2018$31.93M+8.4%
Q4 FY2017Dec 31, 2017$30.74M-13.5%
Q3 FY2017Sep 30, 2017$40.55M+34.7%
Q2 FY2017Jun 30, 2017$30.27M–
Q1 FY2017Mar 31, 2017$29.44M–
Q4 FY2016Dec 31, 2016$35.52M–
Q3 FY2016Sep 30, 2016$30.10M–

More Kyntra Bio figures

See a number that looks wrong?